Recent phase III trials in the frontline treatment of multiple myeloma: evaluating their impact on community practice.
Hemaology Department, University of Salamanca, Salmanca, Spain
Jesus
J
SanMiguel
Thierry
T
Facon
Michele
M
Cavo
D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols; D017326:Clinical Trials, Phase III as Topic; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D012074:Remission Induction / Q000379:methods; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous
D000970:Antineoplastic Agents